Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report
The question of the safety of direct oral anticoagulants (DOACs), despite their high efficacy in the prevention of thrombotic events in atrial fibrillation (AF), remains relevant due to the risk of developing hemorrhagic events while taking standard doses, which requires a thorough personalized appr...
Saved in:
| Main Authors: | A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2023-07-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2900 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants
by: Z. A. Gebekova, et al.
Published: (2022-11-01) -
New prospects for assessing the hemostasis system in atrial fibrillation and left atrial appendage thrombosis
by: Z. A. Gebekova, et al.
Published: (2023-01-01) -
COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01) -
Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF‐TIMI 48 Trial
by: Robert S. Semco, et al.
Published: (2025-01-01) -
HOW TO REDUCE GASTROINTESTINAL BLEEDING RISK ON ANTICOAGULATION THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION?
by: E. I. Baranova, et al.
Published: (2017-11-01)